Treatment of Severe Liver Failure with a Bioartificial Liver a

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1997-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.1997.tb52210.xPMID 9616727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Matrix-Induced Liver Cell Aggregates (MILCA) for Bioartificial Liver Use

  1996cited by this paper
• Automated Liver Cell Processing Facilitates Large Scale Isolation and Purification of Porcine Hepatocytes

  1995cited by this paper
• Early clinical experience with a hybrid bioartificial liver.

  1995cited by this paper
• Support of the Acutely Failing Liver

  1994cited by this paper
• A Bioartificial Liver to Treat Severe Acute Liver Failure

  1994cited by this paper
• Classification of acute liver failure

  1993cited by this paper
• Development of a Hybrid Bioartificial Liver

  1993cited by this paper
• Acute liver failure: redefining the syndromes.

  1993cited by this paper
• Use of a novel bioartificial liver in a patient with acute liver insufficiency.

  1993cited by this paper
• Acute liver failure.

  1993cited by this paper
• Classifying acute liver failure.

  1993cited by this paper
• Successful application of extracorporeal liver perfusion: a technology whose time has come.

  1993cited by this paper
• Development of a bioartificial liver: Properties and function of a hollow‐fiber module inoculated with liver cells

  1993cited by this paper
• Acute and subacute fulminant hepatic failure: the role of liver transplantation

  1991cited by this paper
• Therapeutic plasmapheresis for liver failure after hepatectomy.

  1989cited by this paper
• Performance of a new hybrid artificial liver support system using hepatocytes entrapped within a hydrogel.

  1989cited by this paper
• Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.

  1988cited by this paper
• Fulminant hepatic failure and the need for artificial liver support.

  1988cited by this paper
• A new hybrid artificial liver using a combination of hepatocytes and biomatrix.

  1987cited by this paper
• Hybrid bioartificial liver in hepatic failure: preliminary clinical report.

  1987cited by this paper
• Assessment of level of consciousness following severe neurological insult. A comparison of the psychometric qualities of the Glasgow Coma Scale and the Comprehensive Level of Consciousness Scale.

  1984cited by this paper
• Effects of Serial Resin Hemoperfusion in Fulminant Hepatic Failure

  1983cited by this paper
• Sorption-filtration therapy for chronic liver disease: in vitro testing and clinical correlation.

  1982cited by this paper
• Earlier charcoal haemoperfusion in fulminant hepatic failure.

  1982cited by this paper
• HYPERAMMONÆMIA, PLASMA AMINOACID IMBALANCE, AND BLOOD-BRAIN AMINOACID TRANSPORT: A UNIFIED THEORY OF PORTAL-SYSTEMIC ENCEPHALOPATHY

  1979cited by this paper
• Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane.

  1978cited by this paper
• Hepatic support with hepatocyte suspensions in a permeable membrane dialyzer.

  1977cited by this paper
• Total blood washout and exchange. A valuable tool in acute hepatic coma and Reye's syndrome.

  1977cited by this paper
• Treatment of fulminant hepatic failure by polyacrylonitrile-membrane haemodialysis.

  1977cited by this paper
• Plasma and Brain Amino Acids in Fulminant Hepatic Failure and their Relationship to Hepatic Encephalopathy

  1976cited by this paper
• Controlled trial of exchange-transfusion therapy in fulminant hepatitis.

  1973cited by this paper
• Acute hepatic failure treated by cross circulation.

  1973cited by this paper
• Treatment of acute hepatic coma by ex vivo baboon and human liver perfusions.

  1972cited by this paper
• Extracorporeal pig-liver perfusoon in treatment of hepatic coma due to fulminant hepatitis.

  1971cited by this paper
• The management of fulminant hepatic failure.

  1970cited by this paper

• Bioartificial liver support systems for acute liver failure: A systematic review and meta-analysis of the clinical and preclinical literature

  2019cites this paper
• Tissue Engineering and Artificial Organ

  2017cites this paper
• Potential of Ligno-cellulosic and Protein Fibres in Sustainable Fashion

  2016cites this paper
• Extracorporeal Liver Support and Liver Transplant for Patients with Acute-on-Chronic Liver Failure

  2016cites this paper
• Specialty Chemical Finishes for Sustainable Luxurious Textiles

  2015cites this paper
• Chapter 107 – Current Clinical Status of the Extracorporeal Liver Support Devices

  2015cites this paper
• Systematic review: extracorporeal bio-artificial liver-support system for liver failure

  2012cites this paper
• A CRITICAL EVALUATION OF THE MARS TREATMENT IN FINLAND

  2010cites this paper
• Biochemical studies on the protective effect of Taurine on experimentally induced Fulminat Hepatic failure in rats

  2010cites this paper
• Three-Dimensional Perfusion Bioreactor Culture Supports Differentiation of Human Fetal Liver Cells

  2010cites this paper
• Nanocomposite Calcium Alginate Fibres Containing SiO2 and Bioglass

  2010cites this paper
• Nanokompozytowe włókna alginianowe i kompozyty z ich udziałem do zastosowań w inżynierii biomateriałowej

  2010cites this paper
• Engineering of an Hepatic Organoid to Develop Liver Assist Devices

  2010cites this paper
• Acute liver failure

  2009cites this paper
• In vitro analysis of a hepatic device with intrinsic microvascular-based channels

  2008cites this paper
• Construction and Transplantation of an Engineered Hepatic Tissue Using a Polyaminourethane-Coated Nonwoven Polytetrafluoroethylene Fabric

  2007cites this paper
• Cell-based therapies for acute liver failure: human tissue engineering, pure cell implantation and stem cell application

  2007cites this paper
• Cellular to tissue informatics: approaches to optimizing cellular function of engineered tissue.

  2006cites this paper
• Improved Oxygen Delivery to Hepatic Hollow Fiber Bioreactors

  2006cites this paper
• Attachment evaluation of embryonic stem cells on a pau-coated non-woven fabric: a potential source for bioartificial assist devices

  2006cites this paper
• Differentiation of Human Embryonic Stem Cells to Hepatocytes Using Deleted Variant of HGF and Poly-amino-urethane-Coated Nonwoven Polytetrafluoroethylene Fabric

  2006cites this paper
• Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell–derived hepatocytes

  2006cites this paper
• Acute liver failure in neonates.

  2005cites this paper
• Acute liver failure

  2005cites this paper
• Cartilage tissue engineering. Effects of interleukin-4, insulin-like growth factor binding proteins and biomaterials

  2005cites this paper
• Configuration of a new bioartificial liver support system and in vitro evaluation of its functions.

  2005cites this paper
• Acute liver failure is a complex multisystemic illness that evolves quickly after a catastrophic

  2005cites this paper
• Artificial and bioartificial support systems for liver failure.

  2004cites this paper
• Approaches to acute liver failure in children

  2004cites this paper
• Development of a scaled up liver device incorporating cryo-preserved pig liver micro-organs.

  2004cites this paper
• Remyelination of the nonhuman primate spinal cord by transplantation of H‐transferase transgenic adult pig olfactory ensheathing cells

  2004cites this paper
• Liver regeneration using a hybrid artificial liver support system.

  2004cites this paper
• Circe, Cassandra, and the trojan pigs: xenotransplantation.

  2004cites this paper
• Functional role of RhoA in growth regulation of primary hepatocytes.

  2004cites this paper
• Improvement of C3A cell metabolism for usage in bioartificial liver support systems.

  2004cites this paper
• Cellular therapies for liver replacement.

  2004cites this paper
• Acute liver failure in childhood

  2004cites this paper
• Xenotransplantation--federal regulatory considerations.

  2003cites this paper
• Viral Zoonoses – A Threat under Control?

  2003cites this paper
• Bioartificial liver inoculated with porcine hepatocyte spheroids for treatment of canine acute liver failure model.

  2003cites this paper
• Liver micro-organs transcribe albumin and clotting factors and increase survival of 92% hepatectomized rats.

  2003cites this paper
• Reconstitution of Hepatic Tissues Using Liver Stem Cells

  2002cites this paper
• Extracorporeal Treatment in Fulminant Hepatic Failure: Pathophysiologic Considerations

  2002cites this paper
• Morphology, Viability and Functions of Suckling Pig Hepatocytes Cultured in Serum-Free Medium at High Density

  2002cites this paper
• Phase I Clinical Trial with the AMC-Bioartificial Liver

  2002influential citation
• Plasma versus Whole Blood Perfusion in a Bioartificial Liver Assist Device

  2002cites this paper
• First Clinical Use of a Novel Bioartificial Liver Support System (BLSS) †

  2002cites this paper
• Phase I clinical trial with the AMC-bioartificial liver.

  2002cites this paper
• Transgenic pigs designed to express human CD59 and H‐transferase to avoid humoral xenograft rejection

  2002cites this paper
• Preclinical evaluation of the Excorp Medical, Inc, Bioartificial Liver Support System.

  2002cites this paper
• Advances in Bioartificial Liver Assist Devices

  2001cites this paper
• Xenotransplantation: regulatory challenges.

  2001cites this paper
• Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

  2001cites this paper
• Self-organization of liver constitutive cells mediated by artificial matrix and improvement of liver functions in long-term culture

  2001cites this paper
• Safety Observations in Phase I Clinical Evaluation of the Excorp Medical Bioartificial Liver Support System after the First Four Patients

  2001cites this paper
• Hemodynamic and metabolic variables predict porcine ex vivo liver function.

  2001cites this paper
• Improvement of metabolic performance of cultured hepatocytes by high oxygen tension in the atmosphere.

  2001cites this paper
• The Effect of Serum from Liver Cancer Patients on the Growth and Function of Primary and Immortalised Hepatocytes

  2001influential citation
• Liver transplantation and artificial liver support in fulminant hepatic failure.

  2001cites this paper
• EXTRACORPOREAL LIVER PERFUSION USING HUMAN AND PIG LIVERS FOR ACUTE LIVER FAILURE

  2000cites this paper
• Tissue engineering: challenges and opportunities.

  2000cites this paper
• Prospects for Xenotransplantation of the Liver

  2000cites this paper
• Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord

  2000cites this paper
• A review of bioartificial liver development from an artificial organ engineering perspective

  2000cites this paper
• Xenotransplantation: A summary of the international business communications' fourth international congress

  2000cites this paper
• Comparison of Analytical Methods for Quantitation of Isolated Porcine Hepatocyte Yields

  2000cites this paper
• Isolation and culture of porcine hepatocytes

  2000cites this paper
• CHAPTER 40 – HEPATASSIST LIVER SUPPORT SYSTEM

  2000cites this paper
• Xenotransplantation of the liver.

  2000cites this paper
• Critical care apheresis: hepatic failure.

  1999cites this paper
• Expression of the human α:1,2‐fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum‐mediated cytolysis

  1999cites this paper
• Biochemical Functions and mRNA Expression of Rat Hepatocytes in a Bioartificial Liver Module

  1999cites this paper
• Bioartificial organs may help reduce risk of zoonosis in xenotransplantation.

  1999cites this paper
• Cell Engineering

  1999cites this paper
• Immortalization of Hepatocytes through Targeted Deregulation of the Cell Cycle

  1999cites this paper
• Novel Bioartificial Liver Support System: Preclinical Evaluation

  1999cites this paper
• Xenotransplantation: about baboon hearts and pig livers.

  1998cites this paper
• Acute Liver Failure

  1997cites this paper
• Prospects for xenotransplantation of the liver.

  1996cites this paper
• evaluation of extracorporeal bioartificial liver support system for the treatment of liver failure

  year unknowncites this paper